With headquarters in Cataluña, Noucor is the B2B division of Uriach, the Spanish based family-owned pharmaceutical company which was established in 1838, recently acquired by MCH Private Equity. Uriach is a global player in the pharmaceutical space with sales in over 70 countries worldwide. As part of Uriach’s strategic plan to focus on B2C consumer healthcare, Uriach decided to divest its B2B division. Noucor will focus on three key areas:

i) New Chemical Entities (with the aim to investigate, develop, license and supply new molecules)
ii) Generics, responsible for developing and producing Active Pharmaceutical Ingredients
iii) Contract Manufacturing B2B (where both solid and semi solid products are manufactured at Noucor facilities for other pharmaceutical clients under contract manufacturing agreements)

Noucor logo





Date of Investment

December 2021